The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berg, N. N.
Right arrow Articles by Ostergaard, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berg, N. N.
Right arrow Articles by Ostergaard, H. L.
The Journal of Immunology, 1998, 161: 2919-2924.
Copyright © 1998 by The American Association of Immunologists

Sustained TCR Signaling Is Required for Mitogen-Activated Protein Kinase Activation and Degranulation by Cytotoxic T Lymphocytes1

Nancy N. Berg, Lawrence G. Puente, Wojciech Dawicki and Hanne L. Ostergaard2

Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Requirements for T cell activation are not fully established. One model is that receptor occupancy and down-regulation are essential for activation, and another, not necessarily mutually exclusive, model is that sustained signals are important. Here we examine the importance of signal duration in T cell activation. First, we demonstrate that immobilized, but not soluble cross-linked, Abs to CD3 stimulate degranulation by CTL. The cross-linked Abs are not deficient in their ability to signal since they stimulate the same tyrosine phosphorylation pattern as immobilized Ab, but it is very transient relative to that stimulated by immobilized Ab. Furthermore, novel decreased migratory forms of Lck occur to a significant extent only after stimulation with immobilized Abs. A dramatic difference in the duration of signals is very evident when mitogen-activated protein kinase (MAPK) activity is examined. Immobilized anti-CD3 stimulates very high levels of MAPK activation that is still detectable 1 h after stimulation. In contrast, cross-linked Ab stimulates only transient and incomplete activation of MAPK. Taken together, these results suggest that TCR engagement and induction of tyrosine phosphorylation alone are not sufficient for T cell activation and that the duration of TCR-stimulated signals is critical to attain a functional response.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Tcell receptor for Ag (TCR)/CD3 engagement triggers a myriad of intracellular signaling events ultimately leading to a functional outcome such as cytokine secretion, proliferation, or cell-mediated killing. In recent years, many of these key signaling molecules, how they interact with one another, and their place in the signaling cascades beyond TCR engagement have been elucidated (1, 2). Following TCR engagement, the tyrosine kinase p56lck is thought to phosphorylate the immunoreceptor tyrosine based activation motif (ITAM) sequences in the TCR {zeta}-chains. The tyrosine kinase ZAP70 subsequently associates with the phosphorylated {zeta}-chains, and activation of ZAP70 leads to downstream signaling events (3). Further downstream, through a mechanism that is not fully defined in T cells, is the activation of the Ras pathway leading to mitogen-activated protein (MAP)3 kinase activation (2).

The study of APL has contributed to our understanding of T cell activation (4, 5). Th cells engaging APL have altered TCR {zeta}-chain tyrosine phosphorylation and altered association with, and activation of, ZAP70 (6, 7). Engagement of APL leads to altered signaling in CD8+ cells in the absence of esterase release and cytolysis (8). A hierarchy of cellular responses has been demonstrated in Th cells depending on whether the stimulus is an agonist, partial agonist, or antagonist (9). The different cellular responses following APL engagement indicate that the events of T cell activation can be uncoupled from one another and that TCR/CD3 complex engagement does not always lead to complete activation.

It has been suggested that a threshold of TCR occupancy is necessary for sustained signaling and subsequent T cell activation (10, 11). The formation of intracellular signaling complexes could be an obligatory consequence of TCR occupancy that is necessary for full cellular activation, as suggested by Wange et al. (12). Given this information, it seemed probable that the method of T cell stimulation may influence the activation outcome and may provide insight into the requirements for full T cell activation. We tested the functional differences in stimulating CTL clones with Ab to the TCR/CD3 complex in immobilized and soluble cross-linked form. Our data directly demonstrate that the induction of tyrosine phosphorylation can be uncoupled from a functional response. Furthermore, we present evidence supporting the need for sustained signaling through the TCR/CD3 complex to generate downstream signaling responses and T cell activation as measured by CTL degranulation.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Cell lines

Murine CD8+ CTL clones, clone 11 and clone AB.1 (H-2d anti-H-2b), have been described previously (13). The clones are stimulated weekly with irradiated spleen cells from C57BL/6 mice (The Jackson Laboratory, Bar Harbor, ME) and used 4 to 7 days later.

Abs and reagents

The hybridoma producing 145-2C11 (anti-CD3{epsilon}) was obtained from the American Type Culture Collection (ATCC, Manassas, VA), and PY-72 (anti-phosphotyrosine) was provided by Dr. B. Sefton (The Salk Institute, La Jolla, CA). They were grown in Protein-Free Hybridoma Medium-II (Life Technologies, Burlington, ON), and the Abs were purified by ammonium sulfate precipitation followed by either protein A or protein G chromatography, if required. Anti-MAP kinase (Erk 1) and anti-p56lck mAbs were purchased from Transduction Laboratories (Lexington, KY). Phospho-specific MAP kinase Ab was purchased from New England Biolabs (Beverly, MA). Goat anti-hamster, rabbit anti-hamster, and goat anti-mouseHRP Abs were purchased from Jackson Immunoresearch Laboratories (West Grove, PA). PMA and A23187 were purchased from Sigma Chemical Company (Mississauga, ON) and Calbiochem (San Diego, CA), respectively. The MAP kinase kinase (MEK) inhibitor PD 98059 was purchased from Calbiochem.

Protein immobilization

Ninety-six well, flat-bottom plastic microtiter plates (Becton Dickinson, Oxnard, CA) were coated with 145-2C11 at the indicated concentration overnight at 4°C. Wells were then washed twice with PBS, blocked with 2% BSA in PBS for 30 min at 37°C, and then washed twice with PBS.

Degranulation assay

Degranulation was measured by the release of serine esterase (13). Clone AB.1 or clone 11 cells were washed three times in RPMI 1640 with 2% newborn calf serum. Cells (1.5 x 105) in 150 µl of 2% FCS in RPMI 1640 were added to each well of a microtiter plate. For the soluble cross-linked Ab stimulation, cells at 107 cells per ml were incubated with various concentrations of 145-2C11 for 30 min on ice, washed, and resuspended in RPMI 1640 supplemented with 2% FCS. The cells were added directly to the wells immediately after addition of either 1.0 or 10.0 µg/ml goat anti-hamster Ab. Cells were pretreated with PD 98059 for 30 min at 37°C before addition of the cells to the Ab-coated wells. For assays employing PMA (125 ng/ml) and/or A23187 (50 µM), reagents were added to cells immediately after adding the cross-linking Ab. After 4 to 5 h at 37°C, 25 µl of supernatants were tested for benzyloxycarbonil-L-lysine thiobenzyl ester (BLT)-esterase activity (13). Results were read at 405 nm using a kinetic microplate reader (Molecular Devices, Sunnyvale, CA). All samples were done in triplicate or quadruplicate, and the SD is shown.

Western blotting

CTL clones were harvested and washed in D-PBS (Life Technologies). Cells (1.5 x 105) in 50 µl were stimulated as for the degranulation assay but in serum-free D-PBS. Cells were incubated at 37°C for the indicated times. Cells were lysed by the addition of 40 µl 2x Laemmli reducing sample buffer and boiled for 2 min. Whole cell lysates were loaded on either 7.5% standard (37.5:1 acrylamide:Bis) or 8.5% low Bis (56.6:1 acrylamide:Bis) SDS-PAGE, electrophoresed, and the proteins transferred to Immobilon P (Millipore Corporation, Bedford, MA) overnight at 75 mA. For the MAP kinase mobility shift assays, cell lysates were subjected to SDS-PAGE on a 15% low Bis gel (175:1 acrylamide:Bis). Immunoblotting was done using anti-phosphotyrosine (PY-72), anti-p56lck, or anti-MAP kinase and rabbit anti-mouseHRP Ab. Bound Ab was detected by Enhanced Chemiluminescence (NEN, Life Science Products, Boston, MA).


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
CTL degranulation requires an immobilized stimulus

As we have previously demonstrated (14), immobilized Ab to CD3{epsilon} (145-2C11) or the TCR (H57-597; data not shown) stimulates a degranulation response by CTL clone AB.1 (Fig. 1Go). Cells were plated on microtiter wells coated with 2C11 at various concentrations, and the serine esterase release was assayed to measure degranulation. In contrast, when we performed the same assay using cross-linked Abs, we observed that soluble cross-linked Ab to either CD3{epsilon} (Fig. 1Go) or the TCR (data not shown) was unable to stimulate a degranulation response. Cells were incubated with soluble 2C11 at various concentrations for 30 min on ice. Cells were either used directly or cross-linked with secondary goat anti-hamster Ab at either 1.0 or 10.0 µg/ml. Degranulation significantly above that of background was not observed at a range of both primary and secondary Ab concentrations (Fig. 1Go, and data not shown); no cross-linking conditions were found that could stimulate degranulation above the background control of BSA alone. Ice pretreatment had no effect on the degranulation in response to immobilized anti-CD3 stimulation (data not shown).



View larger version (18K):
[in this window]
[in a new window]
 
FIGURE 1. Immobilized, but not soluble or cross-linked, anti-CD3 triggers CTL degranulation. Clone AB.1 cells (1.5 x 105) were stimulated with immobilized anti-CD3 (IMM 2C11) at 0.05 to 20.0 µg/ml (squares). Alternatively, cells were stimulated with 0.05 to 20.0 µg/ml soluble 2C11 alone (triangles) or followed by cross-linking (XL) with goat anti-hamster at 1.0 µg/ml (diamonds) or 10.0 µg/ml (circles). The blocking protein BSA is used as a background control. Cells were incubated at 37°C for 4 h, and supernatants were assayed for serine esterase release.

 
Immobilized, but not soluble cross-linked, Ab to the TCR complex leads to sustained tyrosine phosphorylation

Since degranulation is a downstream event following TCR engagement and it is not triggered upon soluble Ab cross-linking of the TCR, we examined a more membrane-proximal event. We initially examined the tyrosine phosphorylation of total cellular proteins following both stimulation conditions. This is the earliest event detected thus far following TCR engagement, and a number of studies have shown that cross-linked Ab stimulates tyrosine phosphorylation. When CTL clones are stimulated with soluble cross-linked Ab to CD3, there is an early and transient tyrosine phosphorylation of a number of proteins (Fig. 2Go). Phosphorylation of the majority of proteins occurs by 5 min and begins to diminish by 20 min. Immobilized anti-CD3-stimulated CTL clones have similar levels of protein tyrosine phosphorylation at 10 min compared with soluble cross-linked Ab stimulation, and it is sustained until at least 60 min. Both stimulation conditions yield similar patterns of phosphorylation, with apparently similar proteins becoming phosphorylated to the same extent. The major difference appears to be in the duration of the tyrosine phosphorylation. Even considering an initial lag time for cells to contact the immobilized Ab, the duration of tyrosine phosphorylation is about 15 min for soluble cross-linked stimulation, as compared with 50 min for immobilized conditions. The same results are seen with anti-TCR (H57–597) stimulation by soluble cross-linked and immobilized conditions, respectively (data not shown).



View larger version (92K):
[in this window]
[in a new window]
 
FIGURE 2. Kinetics of protein tyrosine phosphorylation of total cell lysates following anti-CD3 stimulation. Clone AB.1 cells (1.5 x 105) were stimulated with soluble cross-linked (XL) 2C11 and goat anti-hamster Ab each at 10 µg/ml or with immobilized 2C11 at 20 µg/ml and incubated at 37°C for the indicated times. Cell lysates were subjected to SDS-PAGE and anti-phosphotyrosine immunoblotting as described in Materials and Methods.

 
The duration of tyrosine phosphorylation of several immunoprecipitated intracellular proteins follows that of the whole cell lysates (data not shown). The CTLs are therefore capable of quantitatively and qualitatively undergoing the same tyrosine phosphorylation events under both stimulation conditions, with the duration of the signal being the only obvious difference. This indicates that the immobilized stimulus allows for sustained tyrosine phosphorylation that is not achieved when soluble cross-linked stimulation is used. These results demonstrate that induction of tyrosine phosphorylation by a TCR agonist does not per se lead to a functional response.

p56lck undergoes a mobility shift only with immobilized Ab stimulation

TCR/CD3 complex stimulation leads to the recruitment and activation of p56lck. The enzymatic activity of p56lck plays a pivotal role in the downstream tyrosine phosphorylation events that result in T cell activation (15, 16). It has also been shown that p56lck undergoes a mobility shift to p60lck following anti-CD3 stimulation (17, 18, 19). This shift may be due to increased serine phosphorylation of p56lck (17, 18), the function of which is not clearly understood. To determine whether these stimulation conditions lead to this migratory shift, CTL clones were stimulated with either soluble cross-linked or immobilized anti-CD3. Total cell lysates were separated by SDS-PAGE using 8.5% low Bis gels, which have higher resolution in the 40- to 60-kDa range, and probed with a mAb to p56lck. The resulting immunoblot (Fig. 3Go) indicates that, following soluble cross-linked anti-CD3 stimulation, there is a dominant form of p56lck (arrow 1) and a minor higher m.w. form (arrow 2). p56lck from CTLs stimulated with immobilized anti-CD3 undergo a more extensive mobility shift to the higher m.w. form (arrow 2). Also, two higher m.w. p56lck forms (arrows 3 and 4) are present at 30 min following immobilized Ab stimulation, and they are sustained for at least 60 min.



View larger version (35K):
[in this window]
[in a new window]
 
FIGURE 3. Mobility shift of p56lck following immobilized and cross-linked anti-CD3 stimulation. Clone AB.1 cells (1.5 x 105) were stimulated with soluble cross-linked (XL) 2C11 at 10 µg/ml and goat anti-hamster Ab at 10 µg/ml or immobilized 2C11 at 20 µg/ml and incubated at 37°C for the indicated times. Soluble control (C) is goat anti-hamster secondary Ab only, and immobilized control is BSA. Cell lysates were subjected to SDS-PAGE and anti-p56lck immunoblotting as described in Materials and Methods.

 
Failure to induce degranulation by soluble cross-linked Ab is not restored with increased intracellular Ca2+ or protein kinase C (PKC) activation

Recently it was reported that the Ca2+ flux in T cells is more sustained following stimulation with surface-attached ligands than soluble ligands (20). One possibility is that the soluble cross-linking conditions do not stimulate a sustained Ca2+ flux, and we have shown that Ca2+ is required for degranulation by this CTL clone (21). If this is the case, then we should be able to restore degranulation in the CTL clones with a Ca2+ ionophore. Adding the Ca2+ ionophore A23187 and the phorbol ester PMA together triggers CTL degranulation whereas either alone does not (Fig. 4Go). Treatment of cells with A23187 along with soluble cross-linked Ab does not induce degranulation in the CTL clones. Addition of PMA following soluble cross-linking Ab stimulation also does not induce degranulation as compared with the control treatment with both A23187 and PMA. This would indicate that the defect in CTL degranulation is not simply a lack of increased intracellular Ca2+ or protein kinase C (PKC) activation but suggests that both pathways are insufficiently triggered by cross-linked Abs.



View larger version (19K):
[in this window]
[in a new window]
 
FIGURE 4. Failure to induce degranulation by soluble cross-linked Ab is not restored with PMA or A23187. Clone AB.1 cells (1.5 x 105) were stimulated with PMA (125 ng/ml) and/or A23187 (50 µM) alone or with 10 µg/ml soluble cross-linked (XL) 2C11. BSA and immobilized (IMM) 2C11 (20 µg/ml) were used as controls. Cells were incubated at 37°C for 4 h, and supernatants were assayed for serine esterase release.

 
Sustained MAP kinase activation requires an immobilized stimulus

Since both stimulation conditions induce tyrosine phosphorylation in the CTL clones, whereas degranulation is not triggered with soluble cross-linked Ab, we examined another downstream effector outcome following TCR complex stimulation. We examined the consensus MAP kinase activation pathway. Activation of MAP kinase is required for CTL degranulation since PD 98059, an inhibitor of this pathway, decreases the serine esterase release response (Fig. 5Go). Previous data in fibroblasts indicated that MAP kinase activation was dependent on cell anchorage and that greater MAP kinase activation occurred in cells adhering to fibronectin than those in suspension (22). It is possible that similar criteria are necessary for T cells even though T cells are not considered adherent. CTL clones were stimulated as described above, and whole cell lysates were run on a low-Bis 15% SDS-PAGE and immunoblotted for MAP kinase (Fig. 6Go). MAP kinase undergoes decreased mobility due to phosphorylation, which can be used to assess the extent of activation of the enzyme when low-Bis gels are employed. Following soluble cross-linked Ab stimulation, there is transient and partial activation of MAP kinase for about a 5-min duration as indicated by the mobility shift. Following immobilized Ab stimulation, the mobility shift is evident at 20 min, and some shifted material is present even at 60 min. Furthermore, the extent of MAP kinase activation is significantly greater after stimulation with immobilized Abs. These results were confirmed using a phospho-specific MAP kinase Ab that recognizes only catalytically activated p42 and p44 MAP kinases (Fig. 6Go, bottom panel). Again, there is only very transient and limited MAP kinase activation after induction with cross-linked Ab whereas extensive and prolonged MAP kinase activation is induced with immobilized Ab. Thus, for sustained MAP kinase activation, an immobilized stimulus is required.



View larger version (37K):
[in this window]
[in a new window]
 
FIGURE 5. Activation of the MAP kinase pathway is required for degranulation. Clone AB.1 cells (1.5 x 105) were stimulated with immobilized anti-CD3 (2C11) at 20 µg/ml in the absence or presence of the indicated concentration of the MAP kinase kinase (MEK) inhibitor PD 98059. Immobilized BSA was used as a control. Cells were incubated at 37°C for 4 h, and supernatants were assayed for serine esterase release.

 


View larger version (42K):
[in this window]
[in a new window]
 
FIGURE 6. Kinetics of MAP kinase activation following immobilized and soluble cross-linked anti-CD3 stimulation. Clone AB.1 cells (1.5 x 105) were stimulated with soluble cross-linked (XL) 2C11 at 10 µg/ml and rabbit anti-hamster Ab at 5 µg/ml or immobilized 2C11 at 20 µg/ml and incubated at 37°C for the indicated times. The control lanes (C) are from cells incubated on BSA for 20 min. Whole cell lysates were run on a 15% low-Bis gel (upper panel) or a 10% SDS-PAGE gel (lower panel). The samples were then immunoblotted with anti-MAP kinase (upper panel) or anti-phospho-specific MAP kinase (lower panel) as described in Materials and Methods. pp42 indicates the position of the shifted p42.

 
An intact cytoskeleton is required for sustained tyrosine phosphorylation

Upon incubation with soluble cross-linked Ab, there will be a uniform distribution of Ab on the cell surface with most receptors engaged as compared with the more polarized engagement with immobilized Ab. It is plausible that the tyrosine phosphorylation induced with immobilized anti-CD3 requires an intact cytoskeleton, possibly for surface receptor redistribution, to be sustained. We hypothesized that inhibiting cytoskeleton assembly with cytochalasin E treatment would alter the tyrosine phosphorylation differently in the cells stimulated in the two different ways. CTL clones were treated with cytochalasin E before stimulation at 37°C for various times, and tyrosine phosphorylation of total cellular proteins was examined. Figure 7Go shows that cells stimulated with immobilized 2C11 had a near complete inhibition of protein tyrosine phosphorylation in the presence of cytochalasin E (right) as compared with the normal pattern of tyrosine phosphorylation (left). In contrast, cells stimulated with soluble cross-linked 2C11 undergo the same tyrosine phosphorylation events in the absence (left) and presence (right) of cytochalasin E (Fig. 7Go). Consequently, in contrast to the immobilized stimulus, the soluble cross-linked Ab-induced phosphorylation is not inhibited by cytoskeleton disruption.



View larger version (71K):
[in this window]
[in a new window]
 
FIGURE 7. An intact cytoskeleton is required for tyrosine phosphorylation induced by immobilized but not by cross-linked anti-CD3. Clone AB.1 cells (1.5 x 105) were stimulated with immobilized 2C11 at 20 µg/ml or with soluble cross-linked (XL) 2C11 at 10 µg/ml and goat anti-hamster Ab at 10 µg/ml for the indicated times in the absence (left) or presence (right) of 10 µM cytochalasin E. Cell lysates were subjected to SDS-PAGE and anti-phosphotyrosine immunoblotting as described in Materials and Methods.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We have shown that the manner in which you stimulate CTLs, by an immobilized or a soluble cross-linked Ab to the TCR/CD3 complex, results in dramatically different outcomes. Both stimulation conditions trigger qualitatively and quantitatively similar patterns of cellular protein tyrosine phosphorylation, but of different duration. The phosphorylation induced by soluble cross-linked conditions is transient whereas it is sustained when induced by immobilized stimulation. Although soluble cross-linked Abs can trigger tyrosine phosphorylation, degranulation is not stimulated. One may speculate that the sustained phosphorylation is a necessary prerequisite for further downstream effector functions such as degranulation. The immobilized Ab is also necessary to achieve sustained MAP kinase activation and to induce a mobility shift in p56lck. It is therefore evident that tyrosine phosphorylation is not necessarily an indicator of a functional response. Clearly not all stimulation conditions are equal; when cells are stimulated with soluble Ab, the signaling results must be interpreted carefully since a functional response may not be stimulated.

Valitutti et al. (10, 11) have shown that the effector responses elicited from CTLs can be uncoupled from one another, and this is attributed to different levels of TCR occupancy. Glickstein et al. demonstrated that anti-CD3-stimulated apoptosis and cytokine secretion by a Th hybridoma can be uncoupled from each other by using immobilized vs soluble Ab (23). It has also been suggested that T cells have the ability to count the number of TCRs triggered with MHC/peptide (24), and, in the absence of threshold TCR engagement, there is no cell activation. Although our data support that a minimum TCR engagement at the cell surface is necessary for T cell activation, our system suggests that there is more to activating T cells than simple receptor occupancy, since stimulation with soluble cross-linked Ab will result in essentially all the TCR complexes being engaged. Consistent with our results, it has been shown that prolonged TCR/CD3 engagement is needed for a sustained Ca2+ flux, which is required for T cell activation (25). We propose that, under our immobilized Ab conditions, there is a prolonged and sufficient engagement of the TCR complex to allow sustained tyrosine phosphorylation and MAP kinase activation, p56lck mobility shift, and degranulation, none of which is achieved with cross-linked Ab.

TCR engagement leads to down-regulation of TCR surface expression by internalization (24, 26). Engagement of the TCR complex on T cells with soluble cross-linked 2C11, using the same conditions that were used for this study, leads to TCR down-regulation (27), but this is apparently insufficient for activation, as indicated by the lack of degranulation (Fig. 1Go). Recent studies have demonstrated that TCR down-regulation can occur in the absence of T cell activation and that TCR down-regulation does not necessarily lead to subsequent T cell activation (28, 29). Taken together, these data indicate that TCR down-regulation and T cell activation can be uncoupled.

Intracellular signaling events that lead to T cell activation require multimeric complexes to form between signaling molecules and the cytoskeleton (12). Wulfing et al. suggest that the nature of the stimulus will dictate the assembly of intracellular molecules and hence the outcome of stimulation (30). How sustained the TCR engagement is will be important to the formation of such complexes and the subsequent signaling events. Shaw and Dustin (31) also suggest that T cell activation is attained only after the correct signaling complexes have formed and that this requires a given amount of time. The time is needed to provide a stimulus of threshold strength and duration. We propose that this threshold is not achieved with soluble cross-linked Ab, and the absence of these events may result in the lack of effector functions such as degranulation. The necessary strength and/or duration of stimulus is achieved only with the immobilized stimulus. We speculate that the p56lck mobility shift that occurs only following immobilized stimulation may contribute to the formation of such protein complexes, possibly through protein-protein interactions as a result of serine phosphorylation (18).

Previous evidence has shown that the cytoskeleton is necessary for T cell effector functions (32) and that this may be required to sustain the intracellular signals (10). We found that an intact cytoskeleton is required for the sustained tyrosine phosphorylation induced by immobilized Ab and that this is not a requirement for the transient phosphorylation induced by soluble cross-linked Ab (Fig. 7Go). We predict that the cytoskeleton is required for cell spreading on the Ab-coated surface and engagement of sufficient receptors for threshold stimulation. As already discussed, however, TCR occupancy alone is not sufficient for T cell activation, and we conclude that the cytoskeleton is required for the subsequent sustained phosphorylation. The cytoskeleton, either directly or indirectly, is likely needed for the assembly of signaling molecules into multimeric complexes necessary for activation and subsequent effector functions such as degranulation.

Our data show that MAP kinase is activated only transiently with cross-linked Ab but, with immobilized Ab MAP kinase, is activated to a greater extent, and the activation is sustained. Based on a number of studies in neuronal cells, Marshall has proposed that the duration of MAP kinase activation leads to functionally different responses (33). Although our systems differ, our data are in agreement with this model, in that a longer duration of MAP kinase activation correlates with a degranulation response in CTL.

Our results suggest that T cell occupancy is not sufficient to stimulate activation. Since we used high affinity Abs to stimulate activation and the Ab was not limiting in our system, we can assume that essentially all of the receptors were "occupied," yet no degranulation response was observed. On the other hand, if the Abs were immobilized, which does not necessarily change the extent of TCR occupancy, a degranulation response was observed. The striking difference between these two stimulation conditions is that the duration of a number of signals that we measured was significantly longer when immobilized Abs were used. Taken together, these results suggest that the duration of the response, which likely involves cytoskeletal rearrangements, dictates whether a response ensues. This observation can have significant implications for vaccine design since triggering the TCR is not sufficient to guarantee a response, but the duration of the response must also be sustained.


    Acknowledgments
 
We thank Dr. Kevin Kane for helpful discussions and for critically reviewing the manuscript and acknowledge the significant input of Dr. Ellen Shibuya in helping us establish the MAP kinase shift assay in our laboratory.


    Footnotes
 
1 This work was supported by the National Cancer Institute of Canada with funds from the Canadian Cancer Society. N.N.B. is supported by a studentship from the Alberta Heritage Foundation for Medical Research (AHFMR). H.L.O. is a Medical Research Council of Canada Scholar and an AHFMR senior scholar. Back

2 Address correspondence and reprint requests to Dr. Hanne L. Ostergaard, Department of Medical Microbiology and Immunology, 141 Medical Sciences Building, University of Alberta, Edmonton, Alberta, Canada, T6G 2H7. E-mail address: Back

3 Abbreviations used in this paper: MAP, mitogen-activated protein; APL, altered peptide ligands; Bis, N,N'-Methylene-bis-acrylamide. Back

Received for publication March 12, 1998. Accepted for publication May 12, 1998.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Weiss, A., D. R. Littman. 1994. Signal transduction by lymphocyte antigen receptors. Cell 76:263.[Medline]
  2. Cantrell, D.. 1996. T cell antigen receptor signal transduction pathways. Annu. Rev. Immunol. 14:259.[Medline]
  3. Qian, D., A. Weiss. 1997. T cell antigen receptor signal transduction. Curr. Opin. Cell Biol. 9:205.[Medline]
  4. Evavold, B. D., J. Sloan-Lancaster, P. M. Allen. 1993. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol. Today 14:602.[Medline]
  5. Sloan-Lancaster, J., P. M. Allen. 1996. Altered peptide ligand-induced partial T cell activation: molecular mechanism and role in T cell biology. Annu. Rev. Immunol. 14:1.[Medline]
  6. Sloan-Lancaster, J., A. S. Shaw, J. B. Rothbard, P. M. Allen. 1994. Partial T cell signaling: altered phospho-{zeta} and lack of ZAP70 recruitment in APL-induced T cell anergy. Cell 79:913.[Medline]
  7. Madrenas, J., R. L. Wange, J. L. Wang, N. Isakov, L. E. Samelson, R. N. Germain. 1995. Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 267:515.[Abstract/Free Full Text]
  8. Reis e Sousa, C., E. H. Levine, R. N. Germain. 1996. Partial signaling by CD8+ T cells in response to antagonist ligands. J. Exp. Med. 184:149.[Abstract/Free Full Text]
  9. Rabinowitz, J. D., C. Beeson, C. Wulfing, K. Tate, P. M. Allen, M. M. Davis, H. M. McConnell. 1996. Altered T cell receptor ligands trigger a subset of early T cell signals. Immunity 5:125.[Medline]
  10. Valitutti, S., M. Dessing, K. Aktories, H. Gallati, A. Lanzavecchia. 1995. Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy: role of T cell actin cytoskeleton. J. Exp. Med. 181:577.[Abstract/Free Full Text]
  11. Valitutti, S., S. Muller, M. Dessing, A. Lanzavecchia. 1996. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 183:1917.[Abstract/Free Full Text]
  12. Wange, R. L., L. E. Samelson. 1996. Complex complexes: signaling at the TCR. Immunity 5:197.[Medline]
  13. Kane, K. P., L. A. Sherman, M. F. Mescher. 1989. Molecular interactions required for triggering alloantigen-specific cytolytic T lymphocytes. J. Immunol. 142:4153.[Abstract]
  14. Berg, N. N., H. L. Ostergaard. 1995. Characterization of intercellular adhesion molecule-1 (ICAM-1)-augmented degranulation by cytotoxic T cells: ICAM-1 and anti-CD3 must be co-localized for optimal adhesion and stimulation. J. Immunol. 155:1694.[Abstract]
  15. Abraham, N., M. C. Miceli, J. R. Parnes, A. Veillette. 1991. Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck. Nature 350:62.[Medline]
  16. Straus, D. B., A. Weiss. 1992. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70:585.[Medline]
  17. Veillette, A., I. D. Horak, E. M. Horak, M. A. Bookman, J. B. Bolen. 1988. Alterations of the lymphocyte-specific protein tyrosine kinase (p45lck) during T-cell activation. Mol. Cell. Biol. 8:4353.[Abstract/Free Full Text]
  18. Marth, J. D., D. B. Lewis, M. P. Cooke, E. D. Mellins, M. E. Gearn, L. E. Samelson, C. B. Wilson, A. D. Miller, R. M. Perlmutter. 1989. Lymphocyte activation provokes modification of a lymphocyte-specific protein tyrosine kinase (p56lck). J. Immunol. 142:2430.[Abstract]
  19. Caplan, S., M. Baniyash. 1996. Normal T cells express two T cell antigen receptor populations, one of which is linked to the cytoskeleton via {zeta} chain and displays a unique activation-dependent phosphorylation pattern. J. Biol. Chem. 271:20705.[Abstract/Free Full Text]
  20. Hashemi, B. B., J. P. Slattery, D. Holowka, B. Baird. 1996. Sustained T cell receptor-mediated Ca2+ responses rely on dynamic engagement of receptors. J. Immunol. 156:3660.[Abstract]
  21. Ostergaard, H. L., K. P. Kane, M. F. Mescher, W. R. Clark. 1987. Cytotoxic T lymphocyte mediated lysis without the release of serine esterase. Nature 330:71.[Medline]
  22. Lin, T. H., Q. Chen, A. Howe, R. L. Juliano. 1997. Cell anchorage permits efficient signal transduction between Ras and its downstream kinases. J. Biol. Chem. 272:8849.[Abstract/Free Full Text]
  23. Glickstein, L., S. Macphail, O. Stutman. 1996. Uncoupling IL-2 production from apoptosis and TNF production by changing the signal through the TCR. J. Immunol. 156:2062.[Abstract]
  24. Viola, A., A. Lanzavecchia. 1996. T cell activation determined by T cell receptor number and tunable thresholds. Science 273:104.[Abstract]
  25. Donnadieu, E., G. Bismuth, A. Trautmann. 1994. Antigen recognition by helper T cells elicits a sequence of distinct changes of their shape and intracellular calcium. Curr. Biol. 4:584.[Medline]
  26. Valitutti, S., S. Muller, M. Cella, E. Padovan, A. Lanzavecchia. 1995. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375:148.[Medline]
  27. DeBell, K. E., A. Conti, M. A. Alava, T. Hoffman, E. Bonvini. 1992. Microfilament assembly modulates phospholipase C-mediated signal transduction by the TCR/CD3 in murine T helper lymphocytes. J. Immunol. 149:2271.[Abstract]
  28. Cai, Z., H. Kishimoto, A. Brunmark, M. R. Jackson, P. A. Peterson, J. Sprent. 1997. Requirements for peptide-induced T cell receptor down-regulation on naive CD8+ T cells. J. Exp. Med. 185:641.[Abstract/Free Full Text]
  29. Salio, M., S. Valitutti, A. Lanzavecchia. 1997. Agonist-induced T cell receptor down-regulation: molecular requirements and dissociation from T cell activation. Eur. J. Immunol. 27:1769.[Medline]
  30. Wulfing, C., J. D. Rabinowitz, C. Beeson, M. D. Sjaastad, H. M. McConnell, M. M. Davis. 1997. Kinetics and extent of T cell activation as measured with the calcium signal. J. Exp. Med. 185:1815.[Abstract/Free Full Text]
  31. Shaw, A. S., M. L. Dustin. 1997. Making the T cell receptor go the distance: a topological view of T cell activation. Immunity 6:361.[Medline]
  32. O’Rourke, A. M., J. R. Apgar, K. P. Kane, E. Martz, M. F. Mescher. 1991. Cytoskeletal function in CD8- and T cell receptor-mediated interaction of cytotoxic T lymphocytes with class I protein. J. Exp. Med. 173:241.[Abstract/Free Full Text]
  33. Marshall, C. J.. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179.[Medline]



This article has been cited by other articles:


Home page
J. Immunol.Home page
X. Wang, L. Simeoni, J. A. Lindquist, J. Saez-Rodriguez, A. Ambach, E. D. Gilles, S. Kliche, and B. Schraven
Dynamics of Proximal Signaling Events after TCR/CD8-Mediated Induction of Proliferation or Apoptosis in Mature CD8+ T Cells
J. Immunol., May 15, 2008; 180(10): 6703 - 6712.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J.-S. He and H. L. Ostergaard
CTLs Contain and Use Intracellular Stores of FasL Distinct from Cytolytic Granules
J. Immunol., August 15, 2007; 179(4): 2339 - 2348.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Grybko, J. P. Bartnik, G. A. Wurth, A. T. Pores-Fernando, and A. Zweifach
Calcineurin Activation Is Only One Calcium-dependent Step in Cytotoxic T Lymphocyte Granule Exocytosis
J. Biol. Chem., June 22, 2007; 282(25): 18009 - 18017.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. S. Y. Ma, N. Monu, D. T. Shen, I. Mecklenbrauker, N. Radoja, T. F. Haydar, M. Leitges, A. B. Frey, S. Vukmanovic, and S. Radoja
Protein Kinase C{delta} Regulates Antigen Receptor-Induced Lytic Granule Polarization in Mouse CD8+ CTL
J. Immunol., June 15, 2007; 178(12): 7814 - 7821.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. J. Grybko, A. T. Pores-Fernando, G. A. Wurth, and A. Zweifach
Protein kinase C activity is required for cytotoxic T cell lytic granule exocytosis, but the {theta} isoform does not play a preferential role
J. Leukoc. Biol., February 1, 2007; 81(2): 509 - 519.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Laforge, N. Bidere, S. Carmona, A. Devocelle, B. Charpentier, and A. Senik
Apoptotic Death Concurrent with CD3 Stimulation in Primary Human CD8+ T Lymphocytes: A Role for Endogenous Granzyme B
J. Immunol., April 1, 2006; 176(7): 3966 - 3977.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. K. Robertson, L. R. Mireau, and H. L. Ostergaard
A Role for Phosphatidylinositol 3-Kinase in TCR-Stimulated ERK Activation Leading to Paxillin Phosphorylation and CTL Degranulation
J. Immunol., December 15, 2005; 175(12): 8138 - 8145.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. L. Lysechko and H. L. Ostergaard
Differential Src Family Kinase Activity Requirements for CD3{zeta} Phosphorylation/ZAP70 Recruitment and CD3{epsilon} Phosphorylation
J. Immunol., June 15, 2005; 174(12): 7807 - 7814.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Sipione, C. Ewen, I. Shostak, M. Michalak, and R. C. Bleackley
Impaired Cytolytic Activity in Calreticulin-Deficient CTLs
J. Immunol., March 15, 2005; 174(6): 3212 - 3219.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. F. Fierro, G. A. Wurth, and A. Zweifach
Cross-talk with Ca2+ Influx Does Not Underlie the Role of Extracellular Signal-regulated Kinases in Cytotoxic T Lymphocyte Lytic Granule Exocytosis
J. Biol. Chem., June 11, 2004; 279(24): 25646 - 25652.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
T. O. Yarovinsky, M. M. Monick, and G. W. Hunninghake
Integrin Receptors Are Crucial for the Restimulation of Activated T Lymphocytes
Am. J. Respir. Cell Mol. Biol., May 1, 2003; 28(5): 607 - 615.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
L. G. Puente and H. L. Ostergaard
{beta}1/{beta}3 integrin ligation is uncoupled from ERK1/ERK2 activation in cytotoxic T lymphocytes
J. Leukoc. Biol., March 1, 2003; 73(3): 391 - 398.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. D. Edmonds and H. L. Ostergaard
Dynamic Association of CD45 with Detergent-Insoluble Microdomains in T Lymphocytes
J. Immunol., November 1, 2002; 169(9): 5036 - 5042.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Borovsky, G. Mishan-Eisenberg, E. Yaniv, and J. Rachmilewitz
Serial Triggering of T Cell Receptors Results in Incremental Accumulation of Signaling Intermediates
J. Biol. Chem., June 7, 2002; 277(24): 21529 - 21536.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
B. Favier, N. J. Burroughs, L. Wedderburn, and S. Valitutti
TCR dynamics on the surface of living T cells
Int. Immunol., December 1, 2001; 13(12): 1525 - 1532.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
H. S. Warren, A. J. Campbell, J. C. Waldron, and L. L. Lanier
Biphasic response of NK cells expressing both activating and inhibitory killer Ig-like receptors
Int. Immunol., August 1, 2001; 13(8): 1043 - 1052.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. R. Santori, I. Arsov, and S. Vukmanovic
Modulation of CD8+ T Cell Response to Antigen by the Levels of Self MHC Class I
J. Immunol., May 1, 2001; 166(9): 5416 - 5421.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. G. Puente, J. C. Stone, and H. L. Ostergaard
Evidence for Protein Kinase C-Dependent and -Independent Activation of Mitogen-Activated Protein Kinase in T Cells: Potential Role of Additional Diacylglycerol Binding Proteins
J. Immunol., December 15, 2000; 165(12): 6865 - 6871.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. A. Fischer, A. Palmetshofer, S. Gambaryan, E. Butt, C. Jassoy, U. Walter, S. Sopper, and S. M. Lohmann
Activation of cGMP-dependent Protein Kinase Ibeta Inhibits Interleukin 2 Release and Proliferation of T Cell Receptor-stimulated Human Peripheral T Cells
J. Biol. Chem., February 16, 2001; 276(8): 5967 - 5974.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berg, N. N.
Right arrow Articles by Ostergaard, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berg, N. N.
Right arrow Articles by Ostergaard, H. L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS